Difficulty: Medium
Average Score: 81%
Practice
Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin
Correct answer
B
Rationale
The correct answer is B) Blocks the increased risk of endometrial carcinoma due to estrogen. In menopausal women receiving estrogen replacement therapy, unopposed estrogen can lead to hyperplasia of the endometrium, increasing the risk of endometrial carcinoma. Adding a progestin for 10-12 days each month helps counteract this effect by inducing regular shedding of the endometrial lining, reducing the risk of endometrial hyperplasia and carcinoma.
Option A is incorrect because estrogen replacement therapy itself does not significantly increase the risk of myocardial infarction. Option C is incorrect because reversing vulval atrophy is not the primary reason for adding a progestin to estrogen therapy. Option D is incorrect as there is no evidence to suggest that progestins enhance the metabolic benefits of estrogen treatment.
In an educational context, understanding the rationale behind adding a progestin to estrogen therapy in menopausal women is crucial for healthcare professionals, especially those involved in women's health or endocrine pharmacology. This knowledge ensures safe and effective hormone replacement therapy management, considering the potential risks and benefits associated with different hormone regimens.
Option A is incorrect because estrogen replacement therapy itself does not significantly increase the risk of myocardial infarction. Option C is incorrect because reversing vulval atrophy is not the primary reason for adding a progestin to estrogen therapy. Option D is incorrect as there is no evidence to suggest that progestins enhance the metabolic benefits of estrogen treatment.
In an educational context, understanding the rationale behind adding a progestin to estrogen therapy in menopausal women is crucial for healthcare professionals, especially those involved in women's health or endocrine pharmacology. This knowledge ensures safe and effective hormone replacement therapy management, considering the potential risks and benefits associated with different hormone regimens.